Education
About Us
Working with TipRanks
Follow Us
Sanofi (FR:SAN)
:SAN
SAN Stock Chart & Stats
Day’s Range― - ―
52-Week Range€76.78 - €110.88
Previous CloseN/A
Volume78.83K
Average Volume (3M)1.76M
Market Cap
€100.01B
Enterprise Value€108.37B
Total Cash (Recent Filing)€15.36B
Total Debt (Recent Filing)€22.29B
Price to Earnings (P/E)11.1
Beta0.67
Next Earnings
Oct 24, 2025EPS Estimate
2.84Last Dividend Ex-Date
May 12, 2025Dividend Yield4.88%
Share Statistics
EPS (TTM)1.59
Shares Outstanding1,227,469,000
10 Day Avg. Volume2,143,063
30 Day Avg. Volume1,764,116
Financial Highlights & Ratios
PEG Ratio6.99
Price to Book (P/B)1.51
Price to Sales (P/S)2.65
P/FCF Ratio19.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€107.34Price Target Upside30.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
Market GrowthDupixent US prescription growth has accelerated, indicating a more durable franchise than previously appreciated by some investors.
Pipeline PotentialAmlitelimab is seen as having multi-billion-dollar blockbuster potential in patients who fail first-line biologics, such as Dupixent.
Product DevelopmentThe acquisition of Vicebio enhances Sanofi's non-mRNA vaccine pipeline with a promising vaccine candidate for respiratory diseases.
Bears Say
Financial PerformanceThe reimbursement stepdowns from the Dupixent collaboration with REGN are expected to have a negative year-on-year impact of €300M in 2026, followed by a more pronounced €800 million headwind in 2027.
Market CompetitionPhysicians have a high bar for displacing existing treatments like Dupixent, suggesting challenges in gaining market share.
Revenue ForecastThe revenue forecast for 2025 has been revised down by 2% to €43.0B.
Sanofi News
SAN FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was €76.78 and its highest was €110.88 in the past 12 months.
What is Sanofi’s market cap?
Sanofi’s market cap is €100.01B.
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Oct 24, 2025 which is in 77 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Jul 31, 2025. The company reported €1.59 earnings per share for the quarter, missing the consensus estimate of €1.638 by -€0.048.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of €3.92 which represents an annual dividend yield of 4.88%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is 2.84.
How many shares outstanding does Sanofi have?
Sanofi has 1,227,469,000 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of €1.59 in its last earnings report, missing expectations of €1.638. Following the earnings report the stock price went down -7.811%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in FR:SAN
Company Description
Sanofi
Sanofi is a global healthcare company headquartered in Paris, France. It operates in the pharmaceutical and biotechnology sectors, focusing on the research, development, and manufacturing of therapeutic solutions. The company's core products include prescription pharmaceuticals, over-the-counter medications, vaccines, and innovative biologic treatments across a range of therapeutic areas such as diabetes, oncology, immunology, and rare diseases.
SAN Company Deck
SAN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Sanofi reported strong sales growth driven by Immunology and new product launches, with Dupixent continuing its success. The vaccine business also showed robust growth. However, challenges such as expected declines in flu vaccine sales, mixed results for itepekimab, and increased operational expenses present concerns. Strategic acquisitions and sustainability leadership are positive indicators, but potential impacts from U.S. tariffs remain uncertain.View all FR:SAN earnings summariesSAN Stock 12 Month Forecast
Average Price Target
€107.34
▲(30.86% Upside)
Technical Analysis
Ownership Overview
―
Insiders
14.84%
Mutual Funds
<0.01% Other Institutional Investors
71.58% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---